Genetic and environmental factors in prostate cancer genesis: Identifying high-risk cohorts

被引:48
|
作者
Ekman, P [1 ]
机构
[1] Karolinska Hosp, Dept Urol, S-10401 Stockholm, Sweden
关键词
prostate cancer; genetics; environment; diet; receptors;
D O I
10.1159/000019910
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Prostate cancer is the most common malignancy found in males; however, little is as yet known regarding what initiates the disease. The incidence is highest among American Blacks and lowest in the East Asian population. Subtypes of the disease include familial clustering and a hereditary form (9%) supporting genetic events to be involved in prostate cancer pathogenesis. Chromosomal abberations so far identified as being frequently occurring in this disease seem to be related to later phases of disease progression. However, research finding the responsible promoting genetic alteration is rapidly progressing. To explain the varied geographical distribution of the disease, the environment also has to be taken into account. Risk factors identified so far include obesity, animal fat, red meat consumption and certain toxins containing cadmium, while vegetables, cereals and vitamin D seem to be protective. It is reasonable to believe that, in the near future, we will be able to identify persons at risk of acquiring the disease and then inform them how to adjust their lifestyle to avoid early progression of the malignancy.
引用
收藏
页码:362 / 369
页数:8
相关论文
共 50 条
  • [21] Identifying the Best Candidate for Radical Prostatectomy Among Patients with High-Risk Prostate Cancer
    Briganti, Alberto
    Joniau, Steven
    Gontero, Paolo
    Abdollah, Firas
    Passoni, Niccolo M.
    Tombal, Bertrand
    Marchioro, Giansilvio
    Kneitz, Burkhard
    Walz, Jochen
    Frohneberg, Detlef
    Bangma, Chris H.
    Graefen, Markus
    Tizzani, Alessandro
    Frea, Bruno
    Karnes, R. Jeffrey
    Montorsi, Francesco
    Van Poppel, Hein
    Spahn, Martin
    EUROPEAN UROLOGY, 2012, 61 (03) : 584 - 592
  • [22] High-risk prostate cancer: How high is high?
    Sandler, HM
    CANCER JOURNAL, 2002, 8 (04): : 301 - 302
  • [23] Genomics and risk stratification in high-risk prostate cancer
    Al Awamlh, Bashir Al Hussein
    Shoag, Jonathan E.
    NATURE REVIEWS UROLOGY, 2019, 16 (11) : 641 - 642
  • [24] Genomics and risk stratification in high-risk prostate cancer
    Bashir Al Hussein Al Awamlh
    Jonathan E. Shoag
    Nature Reviews Urology, 2019, 16 : 641 - 642
  • [25] HDR brachytherapy for high-risk prostate cancer
    Lo, TCM
    Bouyounes, BT
    Goodman, N
    Bihrle, W
    Roth, RA
    CANCER JOURNAL, 2001, 7 (06): : 527 - 527
  • [26] Radical prostatectomy for high-risk prostate cancer
    Ofer Yossepowitch
    James A. Eastham
    World Journal of Urology, 2008, 26 : 219 - 224
  • [27] High-risk prostate cancer—classification and therapy
    Albert J. Chang
    Karen A. Autio
    Mack Roach
    Howard I. Scher
    Nature Reviews Clinical Oncology, 2014, 11 : 308 - 323
  • [28] Chemotherapy for localized, high-risk prostate cancer
    Narayan, S
    Smith, DC
    Sandler, HM
    SEMINARS IN RADIATION ONCOLOGY, 2003, 13 (02) : 152 - 157
  • [29] Multimodal approaches to high-risk prostate cancer
    Koupparis, A.
    Gleave, M. E.
    CURRENT ONCOLOGY, 2010, 17 : S33 - S37
  • [30] Results of surgery for high-risk prostate cancer
    Joniau, Steven
    Tosco, Lorenzo
    Briganti, Alberto
    Vanden Broeck, Thomas
    Gontero, Paolo
    Karnes, R. Jeffrey
    Spahn, Martin
    Van Poppel, Hein
    CURRENT OPINION IN UROLOGY, 2013, 23 (04) : 342 - 348